Short Term Absorption Study

• Introduce yourself (name, role, and company)
• Tell the potential participant you are calling following their expressed interest in one of our trials.

RDC Clinical is a clinical research organisation within the industries of complementary medicines, dietary supplements, foods and cosmetics.

What is the trial

We are conducting this research to compare the metabolic effects of a natural compound called Oleoylethanolamide (OEA) and a lipid-based dispersion technology, LipiSperse, to an inactive control over an 8-hour period.

We aim to compare the metabolic effects of two different doses of a combination of OEA and LipiSperse to a placebo. We hope to investigate how taking this supplement could potentially support weight management and metabolic health.

We are looking to enrol 40 adults, aged 30 years and older with a BMI 25.0 to 34.9

This study will evaluate two different doses of the combination product compared to an inactive control product (3 products in total)

As this study is a cross-over study, you will be required to take a single dose of all 3 supplements being tested, separated by a week washout period

You will be need to make 3 full-day visits to the RDC Clinical site in Fortitude Valley.
Each study visit will be approximately 9 hours. The study dates for this study are as follows:

Group 5 -

​​Day 1 - Wednesday 21st May
​Day 2 - Wednesday 28th May
​Day 3 - Wednesday 4th June


Would you be available to attend these study dates?

On each of the full day clinic visits, you will be required to arrive fasted, and have a cannula inserted into your arm. This will be used to take blood from you throughout the day to avoid having to repeatedly insert a needle.

Have you had a cannula before?
• If yes, move on
• If no explain what it is and that it will stay in the arm

On each visit, you will arrive to our Fortitude Valley clinic having fasted from 10pm the night before (consuming water is ok).
It is recommended you have a glass of water before leaving home so to ensure your hydration, which can make inserting a cannula easier.
You will have a cannula inserted into a vein inside your elbow and a baseline blood sample taken. Once the cannula is inserted, you will not be able to leave the clinic (until it is removed).
Throughout the day, we will draw blood from the cannula.
We use a cannula for this study so that you do not have to have multiple needle pricks.

Following the baseline sample collection, you will take your allocated trial product along with water.
Each dose of the trial product will consist of 2 small capsules. 15-minutes after taking the trial product, you will be required to provide one more fasting blood sample, then breakfast will be provided immediately after.
Lunch will be provided after the 4-hour blood sample is taken, with snacks provided in the afternoon.

If you complete the study, you will receive a $700 payment.
Are you still interested in proceeding with the trial?
• If no, thank them for their time and wish them well.
• If yes, proceed to the screening criteria.

Now I will go through some screening questions with you to see if you’re eligible to participate. The majority of the questions are to do with your health history.

Do you have any questions about your participation in the study?

Now that you have completed the screening process, if you are happy to proceed, I would like you to sign our electronic consent form. You will receive a link in an email shortly to a secure page where you can sign.

Thank you for your time on the phone, if you have no further questions I will book you in for one of the Study Groups, which one did you prefer?